Article Sidebar

Submitted
Mar 5, 2025
Published
Mar 5, 2025
Download
PDF
Statistic
Read Counter : 22 Download : 10

Main Article Content

Abstract

This study aimed to develop and evaluate an anti-inflammatory gel formulation utilizing Acalypha indica phytoniosomes. Acalypha indica, a traditional medicinal plant, possesses potent anti-inflammatory properties attributed to various bioactive compounds. Phytoniosomes are novel drug delivery systems that combine the therapeutic benefits of plant extracts (phytoconstituents) with the advantages of niosomes. They form stable complexes that enhance the bioavailability, stability, and targeting of the phytoconstituents. The study involved formulating a gel base incorporating Acalypha indica phytoniosomes and evaluating its physicochemical properties (pH, viscosity, spreadability) and in vitro release characteristics. The developed gel demonstrated promising anti-inflammatory potential, with sustained release of Acalypha indica phytoconstituents. This research provides a foundation for further investigation into the clinical application of this novel gel formulation for the management of inflammatory skin conditions.


            

Keywords

niosomes phytoconstituents phytoniosomes delivery systems sustained release formulation

Article Details

How to Cite
K. Neelima Devi, M.L.N.T. Amaleswari, Vikas Kandapu, Karnam Keerthana, Kammari Sai Charan, Kata Sanjay, & Kathi Mahathi. (2025). Phytoniosomal gel of acalypha indica: a novel topical delivery system for anti-inflammatory activity. International Journal of Research in Pharmacology & Pharmacotherapeutics, 14(1), 167-175. Retrieved from https://ijrpp.com/ijrpp/article/view/633
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. 1. Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204-18.
  2. 2. Nordqvist C. ’Everything you need to know about inflammation.’ Med News Today. Medi Lexicon Int. 2017;5(8):6-9.
  3. 3. Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, Götz F, Manosroi W, et al. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm. 2010; 392:304–10.
  4. 4. Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994; 31:81–6.
  5. 5. Hao YM, Li K. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Int J Pharm. 2011; 403:245–53.
  6. 6. Di Marzio L, Marianecci C, Petrone M, Rinaldi F, Carafa M. Novel pH-sensitive non-ionic surfactant vesicles: Comparison between Tween 21 and Tween 20. Colloids Surf B Biointerfaces. 2011; 82:18–24.
  7. 7. Vyas SP. Theory and Practice in Novel Drug Delivery System. New Delhi: CBS Publishers and Distributors; 2009; 284–98.
  8. 8. Bharti N, Loona S, Khan MMU. Proniosomes: A recent advancement in nanotechnology as drug delivery. International Journal of Pharmaceutical Sciences Review and Research. 2012; 12 (1): 67-75.
  9. 9. Karim KM, Mandal AS, Guha A, Chatterjee S, Behera M, Kuotsu K. Niosome: A future of targeted drug delivery systems. Journal of Advanced Pharmaceutical Technology & Research. 2010; 1(4): 374-380
  10. 10. Agrawal A, uyal N, Kukreti G, Yadav C. Niosomes as targeted drug delivery systems. International Journal of Pharmaceutical Sciences Review and Research. 2012; 12(1), 53-60